English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Eli Lilly And Company
Carol Ostrow
| Oct 14, 2017
Lilly wins right to patent Alimta vitamin treatment for certain lung cancers
Carrie Bradon
| Sep 21, 2017
Oncology Data Network called key to improving health care in Europe
Carol Ostrow
| Sep 20, 2017
Lilly study supports Cyramza (ramucirumab) efficacy for treating urothelial carcinoma
Carrie Bradon
| Jul 9, 2017
Japanese Ministry of Health, Labor and Welfare approves Olumiant
Erianne Leatherman
| Jun 21, 2017
Lilly says its galcanezumab cuts down on amount of migraine headache days
Ruth de Jauregui
| Jun 14, 2017
Boehringer Ingelheim, Eli Lilly to collaborate in trial of empagliflozin for chronic kidney disease
Robert Hadley
| Jun 14, 2017
Eli Lilly anti-cancer drug may halt breast cancer spread when paired with fulvestrant
Ruth de Jauregui
| May 21, 2017
Lilly says studies show galcanezumab can reduce migraine episodes
Trending
+
Community
Patient Daily
| Mar 27, 2025
Healthcare professionals recognized at National Breathe Free conference for outstanding dedication
+
Pharmaceuticals
Patient Daily
| Mar 31, 2025
Founder of RXSaveCard on drug pricing: 'We typically see savings of $6,000+ per prescription'
+
Regulatory
Patient Daily News Service
| Mar 28, 2025
Former HHS Official: '340B program is just one of many reminders of the abuse and waste' in D.C.
+
Pharmaceuticals
Patient Daily
| Apr 1, 2025
American Lung Association responds to HHS budget cuts
« First
«
1
2
3
»
Last »